View in EDS HTML Full Text PDF Full Text

Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.

Saved in:
Bibliographic Details
Title: Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.
Authors: Ozkerim U; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Isik D; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Kinikoglu O; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Oksuz S; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Altintas YE; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Akdag G; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Yildirim S; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Basoglu T; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Surmeli H; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Odabas H; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Turan N; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.
Source: Journal of personalized medicine [J Pers Med] 2025 Dec 31; Vol. 16 (1). Date of Electronic Publication: 2025 Dec 31.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41590501
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ozkerim+U%22">Ozkerim U</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Isik+D%22">Isik D</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Kinikoglu+O%22">Kinikoglu O</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Oksuz+S%22">Oksuz S</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Altintas+YE%22">Altintas YE</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Akdag+G%22">Akdag G</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Yildirim+S%22">Yildirim S</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Basoglu+T%22">Basoglu T</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Surmeli+H%22">Surmeli H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Odabas+H%22">Odabas H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Turan+N%22">Turan N</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101602269%22">Journal of personalized medicine</searchLink> [J Pers Med] 2025 Dec 31; Vol. 16 (1). <i>Date of Electronic Publication: </i>2025 Dec 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101602269 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2075-4426 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220754426%22">20754426 </searchLink><i>NLM ISO Abbreviation: </i>J Pers Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41590501
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/jpm16010008
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ozkerim U
      – PersonEntity:
          Name:
            NameFull: Isik D
      – PersonEntity:
          Name:
            NameFull: Kinikoglu O
      – PersonEntity:
          Name:
            NameFull: Oksuz S
      – PersonEntity:
          Name:
            NameFull: Altintas YE
      – PersonEntity:
          Name:
            NameFull: Akdag G
      – PersonEntity:
          Name:
            NameFull: Yildirim S
      – PersonEntity:
          Name:
            NameFull: Basoglu T
      – PersonEntity:
          Name:
            NameFull: Surmeli H
      – PersonEntity:
          Name:
            NameFull: Odabas H
      – PersonEntity:
          Name:
            NameFull: Turan N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2025 Dec 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2075-4426
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of personalized medicine
              Type: main
ResultId 1